Page last updated: 2024-08-24

triazoles and micafungin

triazoles has been researched along with micafungin in 112 studies

Research

Studies (112)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	44 (39.29)	29.6817
2010's	65 (58.04)	24.3611
2020's	3 (2.68)	2.80

Authors

Authors	Studies
Chiou, CC; Groll, AH; Walsh, TJ	1
Habel, F; Hoban, D; Laverdiere, M; Restieri, C	1
Hori, Y; Kohno, S; Matsumori, H; Miyazaki, Y; Mizukane, R; Ohya, S; Sawae, Y; Takesako, K; Uchida, K; Yamaguchi, H; Yoshida, M	1
Mori, T	1
Avila, NA; Bacher, J; Casler, HE; Groll, AH; Kelaher, AM; Lyman, CA; Petraitiene, R; Petraitis, V; Sarafandi, AA; Sein, T; Walsh, TJ	1
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S	1
Kamei, K; Nishimura, K; Zeng, J; Zheng, Y	1
Chandrasekar, PH; Cutright, JL; Manavathu, EK	1
Espinel-Ingroff, A	1
Marr, K	1
Steinbach, WJ	1
Fernández-Torres, B; Guarro, J; Lazéra, Mdos S; Nolard, N; Pastor, FJ; Serena, C; Trilles, L	1
Benjamin, DK; Steinbach, WJ; Zaoutis, TE	1
Kontoyiannis, DP; Lewis, RE	1
Niwa, T; Shiraga, T; Takagi, A	1
Baker, CJ; Pannaraj, PS; Walsh, TJ	1
Ballentine, CS; Glickman, RD; Graybill, JR; Harrison, JM; Kumar, N; Kurian, P; Lloyd, WC; Melendez, R; Miller, A; Miller, MM; Najvar, LK; Paris, G; Patel, AH; Pena, MA; Sponsel, WE; Trigo, Y; Trujillo, F	1
Clemons, KV; Espiritu, M; Parmar, R; Stevens, DA	1
Heyn, K; Müller, FM; Salvenmoser, S; Tredup, A	1
Chamilos, G; Kontoyiannis, DP	1
Asada, N; Komatsu, M; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H	1
Kadota, J; Tokimatsu, I	1
Aperis, G; Mylonakis, E; Spanakis, EK	1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C	1
Alak, A; Buell, D; Holum, M; Keirns, J; Sawamoto, T; Wisemandle, W	1
Maesaki, S	2
Benjamin, DK; Jafri, HS; Mejias, A; Patel, S; Sánchez, PJ; Santos, RP; Walsh, TJ	1
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C	1
Aoun, N; Baixench, MT; Bretagne, S; Dannaoui, E; Desnos-Ollivier, M; Garcia-Hermoso, D; Piketty, C; Ramires, S	1
Hosoki, T; Ikuta, K; Jimbo, J; Kohgo, Y; Nishimura, K; Sano, A; Sato, K; Shindo, M; Torimoto, Y	1
Fujita, M; Harada, E; Ikegame, S; Inoshima, I; Nakanishi, Y; Ouchi, H	1
Scheinfeld, N	1
Mercier, RC; Pai, MP; Samples, ML; Spilde, MN	1
Chu, CC; Hsueh, PR; Ruan, SY	1
Guarro, J; Mariné, M; Ruíz-Cendoya, M	1
Gafter-Gvili, A; Goldberg, E; Leibovici, L; Paul, M; Vidal, L	1
Niimi, K; Niimi, M; Tanabe, K	1
Fujii, Y; Inase, N; Yoshizawa, Y	1
Guarro, J; Mariné, M; Pastor, FJ	1
Calvo, E; Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C	1
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M	1
Baggen, L; Chisholm, J; Sharland, M; Thomas, L	1
Imamura, Y; Kaneko, Y; Kohno, S; Miyazaki, Y; Ohno, H	1
Fukazawa, H; Imamura, Y; Kaneko, Y; Kohno, S; Miyazaki, Y; Murakami, Y; Ohno, H	1
Choi, JH; Choi, SM; Kwon, EY; Lee, DG; Park, CM; Shin, WS; Stevens, DA; Yoo, JH	1
Furuya, A; Ida, K; Kato, M; Koh, K; Okamoto, T; Takita, J	1
Akashi, K; Aoki, T; Harada, N; Iwasaki, H; Kamezaki, K; Miyamoto, T; Mori, Y; Nagafuji, K; Shimono, N; Takenaka, K; Teshima, T; Yamauchi, T; Yoshimoto, G	1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA	1
Beresford, E; Krishna, G; Ma, L; Medlock, M; Noren, C; Power, E; Vickery, D; Yu, X	1
Higashimoto, I; Koreeda, Y; Mataki, H; Matsuda, T; Noma, S; Taira, T	1
Cordonnier, C; Cornely, OA; Flückiger, U; Frêre, P; Gachot, B; Heinz, WJ; Herbrecht, R; Lass-Flörl, C; Maertens, J; Marchetti, O; Ribaud, P; Thiebaut, A	1
Amitani, R; Izumikawa, K; Kakeya, H; Kohno, S; Kurashima, A; Miyazaki, Y; Niki, Y; Ogawa, K; Okimoto, N	1
Abe, M; Fujii, S; Harada, T; Jinno, T; Kagawa, K; Matsumoto, T; Miki, H; Nakamura, S; Nakano, A; Ozaki, S; Takeuchi, K; Yata, K	1
Gyo, K; Hato, N; Hinohira, Y; Hyodo, J; Takahashi, H; Ugumori, T; Wakisaka, H	1
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR	1
Garnacho-Montero, J; Jiménez Parrilla, F	1
Ruiz-Camps, I	1
Jarque, I; Salavert, M	1
Diekema, DJ; Ledeboer, NA; Peterson, JF; Pfaller, MA; Riebe, KM; Rinaldi, MG	1
Clemons, KV; Schwartz, JA; Stevens, DA	1
Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, W; Smith, RP	1
Beiras-Fernandez, A; Bigdeli, AK; Kaczmarek, I; Michel, S; Nickel, T; Reichart, B; Ueberfuhr, P	1
Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Shirotori, S; Tanaka, K; Watanabe, NA; Yoshimatsu, K	1
Hirano, K; Hosogaya, N; Ide, S; Imamura, Y; Iwanaga, N; Izumikawa, K; Kakeya, H; Kohno, S; Kurihara, S; Mihara, T; Minematsu, A; Miyazaki, T; Morinaga, Y; Nakamura, S; Nishino, T; Takazono, T; Tashiro, M; Tashiro, T; Tsukamoto, M; Yamamoto, Y; Yanagihara, K; Yasuoka, A	1
Labbé, AC; Laverdière, M; Levallois, J; Nadeau-Fredette, AC; Ouimet, D; Vallée, M	1
Curfs-Breuker, I; de Hoog, GS; Klaassen, CH; Lackner, M; Meis, JF; Najafzadeh, MJ; Verweij, PE	1
Fortún, J	1
Dukhan, A; Paderu, P; Park, S; Perlin, DS; Senter, M; Zhao, Y	1
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC	1
Feng, G; Li, J; Liu, W; Pang, X; Shang, W; Sun, R; Wang, X; Wang, Y; Zhang, S; Zhang, W	1
Baden, LR; Boukedes, S; Camp, PC; Dietzek, A; Fuhlbrigge, AL; Goldberg, HJ; Issa, NC; Koo, S; Kubiak, DW; Marty, FM	1
Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L	1
Fernandez, JF; Maselli, DJ; Restrepo, MI; Simpson, T	1
Yoshida, M	1
Gibas, CF; Malejczyk, K; Sigler, L; Smith, SW	1
Li, R; Mu, X; Yu, J	1
Badali, H; Curfs-Breuker, I; de Hoog, GS; Deng, S; Liao, W; Meis, JF; Najafzadeh, MJ; Pan, B; Yang, L	1
Furuya, N; Mano, Y; Morishige, H; Oguri, T	1
Curfs-Breuker, I; de Hoog, GS; Feng, P; Meis, JF; Najafzadeh, MJ; Rezaei-Matehkolaei, A; Saradeghi Keisari, M; Shamsian, SA; Vicente, VA	1
Hirose, Y; Kokuzawa, S; Mochizuki, K; Suemori, S; Yaguchi, T	1
Akata, K; Aoki, T; Fujii, M; Hisaoka, M; Ishimoto, H; Kawanami, T; Kinoshita, S; Korogi, Y; Mukae, H; Yatera, K	1
Chang, CY; Chen, KH; Hou, JY; Huang, TH; Liang, DC; Liu, HC; Yeh, TC	1
Bangard, C; Cornely, OA; Shimabukuro-Vornhagen, A; Tran, L; Vehreschild, JJ; Vehreschild, MJ; von Bergwelt-Baildon, M; Wisplinghoff, H	1
Fernández-Silva, F; Guarro, J; Lackner, M; Lass-Flörl, C	1
Angelova, O; Auberger, J; Ditlbacher, A; Lackner, M; Lass-Flörl, C; Nachbaur, D; Orth-Höller, D	1
Fouant, MM; Katragkou, A; Kovanda, LL; McCarthy, M; Meletiadis, J; Moradi, PW; Petraitiene, R; Petraitis, V; Roilides, E; Strauss, GE; Walsh, TJ	1
Al-Hatmi, AM; Bonifaz, A; de Hoog, GS; Garcia-Carmona, K; Meis, JF; van Diepeningen, AD; Vazquez-Maya, L	1
Alves, SH; Ferreiro, L; Jesus, FP; Pilotto, MB; Pötter, L; Santurio, JM; Weiblen, C; Zanette, RA	1
Benjamin, DK; Botero-Calderon, L; Cohen-Wolkowiez, M	1
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Rhomberg, PR	1
Chowdhary, A; Curfs-Breuker, I; de Hoog, GS; Hagen, F; Madrid, H; Meis, JF	1
Hall, RG; Payne, KD	1
Carlson, D; Mattioni, J; Moore, JE; Portnoy, JE; Sataloff, RT	1
Lanternier, FL; Lortholary, O; Pilmis, B	1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Koenderink, JB; Lempers, VJ; Russel, FG; van den Heuvel, JJ	1
Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E	1
Biehl, LM; Bücker, V; Cornely, OA; Franke, B; Liss, B; Markiefka, B; Persigehl, T; Scheid, C; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H	1
Alqarihi, A; Azie, N; Edwards, JE; Gebremariam, T; Ibrahim, AS; Uppuluri, P; Wiederhold, NP	1
Hussain, K; Katragkou, A; Kovanda, LL; McCarthy, M; Meletiadis, J; Moradi, PW; Myint, KL; Petraitiene, R; Petraitis, V; Roilides, E; Strauss, GE; Walsh, TJ; Zaw, MH	1
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K	1
Hope, WW; Hussain, K; Kovanda, LL; Maung, BBW; McCarthy, MW; Petraitiene, R; Petraitis, V; Sekhon, NK; Shaikh, N; Walsh, TJ; Zaw, MH	1
Ho, CL; Lee, CH; Lin, C; Lin, JC; Sun, M; Yen, WT	1
Badali, H; Chowdhary, A; Dannaoui, E; Fakhim, H; Meis, JF; Prakash, A; Vaezi, A	1
Courbin, V; Dannaoui, E; Jullien, V; Raffetin, A	1
Chen, J; Qian, L; Shen, J; Yang, X; Zhang, Y	1
Berman, E; Epstein, DJ; Frattini, MG; Huang, YT; Klimek, VM; Papanicolaou, GA; Park, JH; Seo, SK; Tallman, MS	1
Kwa, LHA; Lee, HLW; Lim, TP; Tan, BH; Tan, SYM; Tan, TT; Tang, SLS; Wong, GC; Zhou, PY	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1
Demmler-Harrison, GJ; Dinu, D; Fatemizadeh, R; Rodman, E	1
Bae, NY; Byun, JM; Choe, PG; Kang, CK; Kim, MS; Kim, NJ; Park, KJ; Yoon, SS	1
Meng, XX; Su, CZ; Su, F; Zhang, JL	1

Reviews

28 review(s) available for triazoles and micafungin

Article	Year
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. The oncologist, 2000, Volume: 5, Issue:2 Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2000
[Issues in the development of drugs for treating deep-seated mycosis]. Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2002, Volume: 43, Issue:4 Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Depsipeptides; Drug Approval; Drug Design; Echinocandins; Glucosyltransferases; Hexosyltransferases; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Structure-Activity Relationship; Triazoles	2002
[Aspergillosis]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Biomarkers; Diagnosis, Differential; Echinocandins; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Serologic Tests; Triazoles; Voriconazole	2003
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Revista iberoamericana de micologia, 2003, Volume: 20, Issue:4 Topics: Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycology; Peptides, Cyclic; Triazoles	2003
Combination antifungal therapy: where are we now, and where are we going? Oncology (Williston Park, N.Y.), 2004, Volume: 18, Issue:13 Suppl 7 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Azoles; Candidiasis; Caspofungin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole	2004
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
Antifungal treatment in pediatric patients. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2005, Volume: 8, Issue:4 Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles	2005
[Drug-drug interaction of antifungal drugs]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2005, Volume: 125, Issue:10 Topics: Antifungal Agents; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Echinocandins; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Miconazole; Microsomes, Liver; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Update on antifungal drug resistance mechanisms of Aspergillus fumigatus. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2005, Volume: 8, Issue:6 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Terbinafine; Triazoles	2005
[Efficacies and clinical roles of new antifungal agents]. Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2006, Volume: 47, Issue:3 Topics: Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2006
New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Oct-15, Volume: 43, Issue:8 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Clinical Trials as Topic; Cryptococcosis; Echinocandins; Fever; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neutropenia; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2006
[The future of antifungal agents]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Drug Therapy; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Pyrimidines; Stem Cell Transplantation; Triazoles; Voriconazole	2007
[New development in the treatment of deep-seated mycoses]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Sep-10, Volume: 96, Issue:9 Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Echinocandins; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole	2007
A review of the new antifungals: posaconazole, micafungin, and anidulafungin. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:12 Topics: Administration, Oral; Anidulafungin; Antifungal Agents; Dermatomycoses; Echinocandins; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Micafungin; Triazoles	2007
Treatment of invasive candidal infections: systematic review and meta-analysis. Mayo Clinic proceedings, 2008, Volume: 83, Issue:9 Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Confidence Intervals; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Odds Ratio; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2008
[What's new in the molecular basis of antifungal drug resistance in pathogenic yeasts]. Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12 Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Mutation; Pyrimidines; Saccharomyces cerevisiae Proteins; Sterols; Trans-Activators; Triazoles; Voriconazole	2008
[Clinical efficacies of antifungal injections]. Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:12 Topics: Amphotericin B; Antifungal Agents; Drug Delivery Systems; Echinocandins; Fluconazole; Humans; Infusions, Intravenous; Injections; Itraconazole; Lipopeptides; Liposomes; Micafungin; Mycoses; Organophosphates; Pyrimidines; Triazoles; Voriconazole	2008
Diagnosis and treatment of aspergillosis in children. Expert review of anti-infective therapy, 2009, Volume: 7, Issue:4 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Echinocandins; Fungal Vaccines; Genomics; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2009
Traditional and emerging antifungal therapies. Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2010
[Drug interactions in critically-ill patients. An important factor in the use of micafungin?]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2 Topics: Adult; Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Child; Critical Illness; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Echinocandins; Humans; Infant, Newborn; Lipopeptides; Micafungin; Microsomes, Liver; Mycoses; Triazoles	2011
[Combination therapy for invasive aspergillosis]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Echinocandins; Forecasting; Fungemia; Guinea Pigs; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Meningitis, Fungal; Micafungin; Mice; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Retrospective Studies; Triazoles	2011
[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2 Topics: Adult; Ambulatory Care; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Male; Meta-Analysis as Topic; Micafungin; Mycoses; Postoperative Complications; Practice Guidelines as Topic; Triazoles	2011
Ten-year experience with fungal peritonitis in peritoneal dialysis patients: antifungal susceptibility patterns in a North-American center. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2012, Volume: 16, Issue:1 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Mycoses; North America; Peritoneal Dialysis; Peritonitis; Pyrimidines; Triazoles; Voriconazole	2012
[Antifungal therapy update: new drugs and medical uses]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 5 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles	2011
Advances in the treatment of invasive neonatal candidiasis. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:7 Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Deoxycholic Acid; Drug Combinations; Echinocandins; Humans; Infant, Newborn; Lipopeptides; Micafungin; Triazoles	2015
Dosing of antifungal agents in obese people. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Obesity; Pyridines; Triazoles	2016
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:9 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence	2016
Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials. PloS one, 2017, Volume: 12, Issue:7 Topics: Adolescent; Adult; Antifungal Agents; Child; Echinocandins; Female; Humans; Leukemia; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Triazoles	2017

Trials

6 trial(s) available for triazoles and micafungin

Article	Year
Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2007
Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin. Journal of clinical pharmacology, 2011, Volume: 51, Issue:1 Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Area Under Curve; Caspofungin; Drug Interactions; Echinocandins; Female; Humans; Infusions, Intravenous; Lipopeptides; Male; Micafungin; Triazoles; Young Adult	2011
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan. The Journal of infection, 2010, Volume: 61, Issue:5 Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Chronic Disease; Echinocandins; Female; Humans; Infusions, Intravenous; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole	2010
Comparison of micafungin and voriconazole in the treatment of invasive fungal infections in kidney transplant recipients. Journal of clinical pharmacy and therapeutics, 2012, Volume: 37, Issue:6 Topics: Adult; Aged; Antifungal Agents; China; Echinocandins; Female; Humans; Kidney Transplantation; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Survival Rate; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2012
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients. European journal of haematology, 2014, Volume: 93, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Echinocandins; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Triazoles	2014
Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study. The Journal of infection, 2018, Volume: 77, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Humans; Incidence; Leukemia; Male; Micafungin; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Survival Analysis; Treatment Failure; Triazoles	2018

Other Studies

78 other study(ies) available for triazoles and micafungin

Article	Year
In vitro activity of three new triazoles and one echinocandin against Candida bloodstream isolates from cancer patients. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:1 Topics: Antifungal Agents; Blood; Candida; Candidiasis; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole	2002
Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. The Journal of infectious diseases, 2003, Jun-15, Volume: 187, Issue:12 Topics: Animals; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Organ Size; Peptides, Cyclic; Rabbits; Thiazoles; Triazoles	2003
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents. Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology, 2004, Volume: 45, Issue:2 Topics: Antifungal Agents; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2004
Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:10 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Guinea Pigs; Lipopeptides; Lipoproteins; Lung; Lung Diseases, Fungal; Micafungin; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Voriconazole	2004
In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:7 Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Drug Interactions; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Triazoles	2005
Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Antifungal Agents; Aspergillus; Drug Combinations; Echinocandins; Fluorescence; Fungal Proteins; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Fluorescence; Peptides, Cyclic; Pyrimidines; Staining and Labeling; Triazoles; Voriconazole	2005
Advances in antifungal therapy. The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole	2005
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits. Documenta ophthalmologica. Advances in ophthalmology, 2005, Volume: 110, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Echinocandins; Electroretinography; Endophthalmitis; Eye Infections, Fungal; Follow-Up Studies; Lipopeptides; Lipoproteins; Micafungin; Ophthalmoscopy; Peptides, Cyclic; Pyrimidines; Rabbits; Retina; Triazoles; Vitreous Body; Voriconazole	2005
Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lipoproteins; Liposomes; Micafungin; Mice; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2005
Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:12 Topics: Antifungal Agents; Aspergillus; Candida; Drug Synergism; Drug Therapy, Combination; Echinocandins; Fusarium; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2005
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Aug-15, Volume: 43, Issue:4 Topics: Acute Disease; Antifungal Agents; Aspergillosis; Echinocandins; Fungemia; Humans; Leukemia, Myeloid; Lipopeptides; Lipoproteins; Male; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Triazoles; Trichosporon; Voriconazole	2006
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole	2006
Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin. The Pediatric infectious disease journal, 2007, Volume: 26, Issue:4 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Dermatomycoses; Echinocandins; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2007
Combined therapies in a murine model of blastoschizomycosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:7 Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole	2007
Acquired resistance to echinocandins in Candida albicans: case report and review. The Journal of antimicrobial chemotherapy, 2007, Volume: 59, Issue:6 Topics: Adult; Amino Acid Sequence; Amino Acid Substitution; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Genotype; HIV Infections; HIV-1; Humans; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Pyrimidines; Treatment Failure; Triazoles; Voriconazole	2007
[Breakthrough pulmonary mucormycosis during voriconazole treatment after reduced-intensity cord blood transplantation for a patient with acute myeloid leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:5 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Cord Blood Stem Cell Transplantation; Echinocandins; Fatal Outcome; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Mucormycosis; Peptides, Cyclic; Pyrimidines; Transplantation Conditioning; Triazoles; Voriconazole	2007
Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007, Volume: 13, Issue:4 Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Necrosis; Pyrimidines; Radiography; Triazoles; Voriconazole	2007
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole	2008
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Combined therapy in treatment of murine infection by Fusarium solani. The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3 Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Drug Therapy, Combination; Echinocandins; Fusarium; Immunocompromised Host; Kidney; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mycoses; Pyrimidines; Spleen; Survival Analysis; Triazoles; Voriconazole	2008
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana. Medical mycology, 2009, Volume: 47, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Male; Micafungin; Mice; Mycoses; Treatment Outcome; Triazoles	2009
Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Humans; Kidney; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mycetoma; Pyrimidines; Scedosporium; Treatment Outcome; Triazoles; Voriconazole	2009
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:1 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2009
The effects of an hsp90 inhibitor on the paradoxical effect. Japanese journal of infectious diseases, 2009, Volume: 62, Issue:5 Topics: Animals; Antifungal Agents; Candida albicans; Echinocandins; Enzyme Inhibitors; Fungi; HSP90 Heat-Shock Proteins; Lipopeptides; Macrolides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2009
Anti-Candida-biofilm activity of micafungin is attenuated by voriconazole but restored by pharmacological inhibition of Hsp90-related stress responses. Medical mycology, 2010, Volume: 48, Issue:4 Topics: Antifungal Agents; Biofilms; Calcineurin; Candida albicans; Dose-Response Relationship, Drug; Echinocandins; Gene Expression Regulation, Fungal; HSP90 Heat-Shock Proteins; Lipopeptides; Micafungin; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole	2010
Immunomodulatory effects of antifungal agents on the response of human monocytic cells to Aspergillus fumigatus conidia. Medical mycology, 2010, Volume: 48, Issue:5 Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Cell Line; Cell Survival; Echinocandins; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Lipopeptides; Micafungin; Monocytes; Pyrimidines; Spores, Fungal; Triazoles; Tumor Necrosis Factor-alpha; Voriconazole	2010
Voriconazole-micafungin combination therapy for acute lymphoblastic leukemia. Pediatrics international : official journal of the Japan Pediatric Society, 2010, Volume: 52, Issue:1 Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida tropicalis; Candidiasis; Drug Therapy, Combination; Echinocandins; Follow-Up Studies; Fungemia; Humans; Infant; Lipopeptides; Male; Micafungin; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pulmonary Aspergillosis; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole	2010
Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy. Mycoses, 2011, Volume: 54, Issue:4 Topics: Amphotericin B; Antifungal Agents; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Micafungin; Middle Aged; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole	2011
A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:12 Topics: Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Empyema, Pleural; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Pleural Effusion; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole	2010
European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone marrow transplantation, 2011, Volume: 46, Issue:5 Topics: Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia; Lipopeptides; Micafungin; Mycoses; Neutropenia; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole	2011
[Multiple myeloma complicated with disseminated zygomycosis after bortezomib therapy]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:8 Topics: Acidosis; Aged; Antifungal Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Echinocandins; Fatal Outcome; Humans; Lipopeptides; Male; Micafungin; Multiple Myeloma; Pyrazines; Pyrimidines; Triazoles; Tumor Lysis Syndrome; Voriconazole; Zygomycosis	2010
Clinical features and outcomes of four patients with invasive fungal sinusitis. Auris, nasus, larynx, 2011, Volume: 38, Issue:2 Topics: Aged; Antifungal Agents; Aspergillosis; Biopsy; Blindness; Brain Infarction; Candidiasis; Cavernous Sinus; Combined Modality Therapy; Debridement; Early Diagnosis; Echinocandins; Fatal Outcome; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lipopeptides; Magnetic Resonance Imaging; Male; Maxillary Sinusitis; Micafungin; Middle Aged; Orbit Evisceration; Orbital Diseases; Postoperative Complications; Pyrimidines; Sphenoid Sinusitis; Tomography, X-Ray Computed; Triazoles; Voriconazole	2011
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp. Journal of clinical microbiology, 2011, Volume: 49, Issue:5 Topics: Antifungal Agents; Automation; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; United States	2011
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis. Medical mycology, 2011, Volume: 49, Issue:8 Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole	2011
Time-kill studies with micafungin and voriconazole against Candida glabrata intracellularly in human monocyte-derived macrophages and extracellularly in broth. Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:4 Topics: Antifungal Agents; Candida glabrata; Drug Synergism; Echinocandins; Humans; Lipopeptides; Macrophages; Micafungin; Microbial Sensitivity Tests; Microbial Viability; Pyrimidines; Time Factors; Triazoles; Voriconazole	2011
Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2011, Volume: 9, Issue:4 Topics: Antifungal Agents; Drug Therapy, Combination; Echinocandins; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole	2011
In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10 Topics: Aminopyridines; Amphotericin B; Antifungal Agents; Aspergillus; Candida; Cell Line; Echinocandins; Fluconazole; Fungi; Fusarium; Humans; Isoxazoles; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Paecilomyces; Pseudallescheria; Pyrimidines; Scedosporium; Triazoles; Voriconazole; Yeasts	2011
Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:1 Topics: Amino Acid Substitution; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Echinocandins; Female; Fungal Proteins; Humans; Itraconazole; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Mutation; Pyrimidines; Sequence Analysis, DNA; Triazoles; Voriconazole	2012
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Bacterial Typing Techniques; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pseudallescheria; Pyrimidines; Scedosporium; Species Specificity; Triazoles; Voriconazole	2012
Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Echinocandins; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Fungal; Humans; Lipopeptides; Micafungin; Pyrimidines; RNA, Messenger; Transcriptome; Treatment Outcome; Triazoles; Voriconazole	2012
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis. Transplantation, 2012, Aug-15, Volume: 94, Issue:3 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cohort Studies; Echinocandins; Female; Humans; Lipopeptides; Lung Transplantation; Male; Micafungin; Middle Aged; Mycoses; Risk; Time Factors; Triazoles	2012
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole	2012
Pulmonary mucormycosis: what is the best strategy for therapy? Respiratory care, 2013, Volume: 58, Issue:5 Topics: Acute Kidney Injury; Adult; Amphotericin B; Antifungal Agents; Debridement; Echinocandins; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Micafungin; Mucormycosis; Pneumonectomy; Triazoles	2013
[Infectious diseases: progress in diagnosis and treatment. Topics: IV. Towards containing infectious diseases: 3. Development of new antifungal drugs]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2012, Nov-10, Volume: 101, Issue:11 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Humans; Itraconazole; Lipopeptides; Micafungin; Mycoses; Pyrimidines; Triazoles; Voriconazole	2012
Invasive sino-orbital mycosis in an aplastic anemia patient caused by Neosartorya laciniosa. Journal of clinical microbiology, 2013, Volume: 51, Issue:4 Topics: Aged; Anemia, Aplastic; Antifungal Agents; Debridement; DNA, Fungal; Echinocandins; Eye Enucleation; Fungal Proteins; Humans; Lipopeptides; Male; Micafungin; Molecular Sequence Data; Mycoses; Neosartorya; Orbital Diseases; Phylogeny; Pyrimidines; Sequence Analysis, DNA; Sequence Homology; Sinusitis; Triazoles; Voriconazole	2013
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin. Journal of clinical microbiology, 2013, Volume: 51, Issue:4 Topics: Aged; Antifungal Agents; DNA, Fungal; Echinocandins; Emericella; Exudates and Transudates; Galactose; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Microscopy; Molecular Sequence Data; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole	2013
In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:4 Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Chromoblastomycosis; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2013
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp. The Japanese journal of antibiotics, 2012, Volume: 65, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Exophiala; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole	2013
Aspergillus tubingenesis endophthalmitis after cataract surgery with implantation of preloaded intraocular lens. Seminars in ophthalmology, 2014, Volume: 29, Issue:4 Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Device Removal; Drug Therapy, Combination; Echinocandins; Endophthalmitis; Eye Infections, Fungal; Humans; Intravitreal Injections; Lens Implantation, Intraocular; Lipopeptides; Male; Micafungin; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Visual Acuity; Vitrectomy; Voriconazole	2014
Disseminated pulmonary penicilliosis in a rheumatoid arthritis patient. Journal of thoracic imaging, 2014, Volume: 29, Issue:2 Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Echinocandins; Humans; Hydrocortisone; Lipopeptides; Lung; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole	2014
Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis. Cancer, 2014, Apr-15, Volume: 120, Issue:8 Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Child; Child, Preschool; Ciprofloxacin; Cohort Studies; Drug Costs; Echinocandins; Female; Humans; Infant; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sepsis; Triazoles; Voriconazole	2014
Assessing micafungin/triazole combinations for the treatment of invasive scedosporiosis due to Scedosporium apiospermum and Scedosporium boydii. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:11 Topics: Animals; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mycoses; Random Allocation; Scedosporium; Triazoles	2014
Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study. European journal of haematology, 2015, Volume: 94, Issue:3 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Administration Schedule; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Retrospective Studies; Transplantation, Homologous; Triazoles; Trichosporon; Trichosporonosis	2015
In vitro combination of isavuconazole with micafungin or amphotericin B deoxycholate against medically important molds. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Cunninghamella; Deoxycholic Acid; Drug Combinations; Drug Interactions; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mucormycosis; Nitriles; Pyridines; Triazoles	2014
Keratitis by Fusarium temperatum, a novel opportunist. BMC infectious diseases, 2014, Nov-12, Volume: 14 Topics: Amphotericin B; Antifungal Agents; Base Sequence; DNA, Fungal; Echinocandins; Fungal Proteins; Fusarium; Humans; Keratitis; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Mycoses; Phylogeny; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Tubulin; Zea mays	2014
Micafungin alone and in combination therapy with deferasirox against Pythium insidiosum. Journal de mycologie medicale, 2015, Volume: 25, Issue:1 Topics: Animals; Antifungal Agents; Benzoates; Deferasirox; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Horse Diseases; Horses; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pythiosis; Pythium; Rabbits; Triazoles	2015
Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and prop Diagnostic microbiology and infectious disease, 2015, Volume: 82, Issue:4 Topics: Antifungal Agents; Drug Resistance, Fungal; Echinocandins; Fungi; Global Health; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Nitriles; Opportunistic Infections; Pyridines; Triazoles	2015
In Vitro Activities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Antifungal Agents; Ascomycota; Caspofungin; Echinocandins; Fluconazole; Genotype; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Nitriles; Pyridines; Triazoles; Voriconazole	2015
Laryngotracheal mucormycosis: Report of a case. Ear, nose, & throat journal, 2016, Volume: 95, Issue:1 Topics: Antifungal Agents; Burkitt Lymphoma; Debridement; Dysphonia; Echinocandins; Hepatitis C, Chronic; HIV Infections; Humans; Hyperbaric Oxygenation; Laryngitis; Laryngoscopy; Lipopeptides; Male; Micafungin; Middle Aged; Mucormycosis; Neurosyphilis; Respiratory Distress Syndrome; Respiratory Sounds; Tracheitis; Tracheotomy; Triazoles	2016
[NEW ANTIFUNGAL DRUGS FOR PREVENTION AND TREATMENT OF VISCERAL MYCOSES]. La Revue du praticien, 2015, Volume: 65, Issue:10 Topics: Antifungal Agents; Caspofungin; Drug Therapy; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole	2015
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Amphotericin B; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Echinocandins; Fluconazole; HEK293 Cells; Humans; Itraconazole; Lipopeptides; Micafungin; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Triazoles; Voriconazole	2016
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9 Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Cohort Studies; Echinocandins; Female; Hematologic Diseases; Humans; Incidence; Invasive Fungal Infections; Itraconazole; Lipopeptides; Male; Micafungin; Middle Aged; Triazoles; Young Adult	2016
Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis. The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:2 Topics: Animals; Antifungal Agents; Drug Therapy, Combination; Echinocandins; Lipopeptides; Lung; Male; Micafungin; Mice; Microbial Sensitivity Tests; Mucor; Mucormycosis; Nitriles; Pyridines; Rhizopus; Triazoles	2017
In vitro combination therapy with isavuconazole against Candida spp. Medical mycology, 2017, Nov-01, Volume: 55, Issue:8 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Invasive; Drug Synergism; Echinocandins; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Time Factors; Triazoles	2017
Changing epidemiology of candidaemia in Australia. The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4 Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole	2017
Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9 Topics: Animals; Antifungal Agents; Combined Modality Therapy; Echinocandins; Female; Galactose; Glucans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung; Mannans; Micafungin; Nitriles; Pyridines; Rabbits; Triazoles	2017
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Antifungal Agents; Candida; Caspofungin; Drug Interactions; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Triazoles; Voriconazole	2017
Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus nidulans; Aspergillus niger; Drug Combinations; Drug Resistance, Fungal; Humans; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2018
Successful Treatment of Lung Aspergillus terreus Infection After a Second Hematopoietic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2019, Volume: 17, Issue:3 Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Humans; Male; Micafungin; Myelodysplastic Syndromes; Postoperative Complications; Pulmonary Aspergillosis; Remission Induction; Triazoles; Young Adult	2019
Subtherapeutic posaconazole troughs despite high-dose posaconazole tablets in a patient with terminal ileum resection. The Journal of infection, 2019, Volume: 78, Issue:5 Topics: Humans; Ileum; Leukemia; Micafungin; Myelodysplastic Syndromes; Tablets; Triazoles	2019
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019
Rhizopus Infection in a Preterm Infant: A Novel Use of Posaconazole. The Pediatric infectious disease journal, 2020, Volume: 39, Issue:4 Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Infant, Newborn; Infant, Premature; Male; Micafungin; Microbial Sensitivity Tests; Mucormycosis; Rhizopus; Triazoles	2020
Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia: A case report. Medicine, 2022, Jan-28, Volume: 101, Issue:4 Topics: Adult; Antifungal Agents; fms-Like Tyrosine Kinase 3; Humans; Intestinal Perforation; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Micafungin; Pyrimidines; Thoracic Injuries; Triazoles; Voriconazole	2022
A case of drug-induced myopathy in alcoholic cirrhosis caused by voriconazole. European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:9 Topics: Aged; Antifungal Agents; Humans; Liver Cirrhosis, Alcoholic; Micafungin; Triazoles; Voriconazole	2023